Form 4 for HCAT Health Catalyst, Inc.
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001562180-22-002340 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-03 | 2022-03-01+ | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $26.64 | -13.3K | 350.5K | -4% | -$354.3K |
| M | 2022-03-03 | 2022-03-01 | HCAT | Burton Daniel D. | CEO, Dir | A - Grant | $0.00 | +11.9K | 354.0K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-02 | F | D | 1,862 | $26.69 | 360,526 | D | — | — | (F5) Represents the weighted average sale price of the shares sold ranging from $25.29 to $27.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (5). |
| 2 | Common | Common Stock | 2022-03-01 | A | A | 8,385 | $0.00 | 362,388 | D | — | — | (F4) Represents an award of 8,385 PRSUs pursuant to the 2019 Plan. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2021, 25% of the PRSUs noted above vested on March 1, 2022 and, thereafter, the remaining 75% of the PRSUs will vest in 12 equal quarterly installments. |
| 3 | Common | Common Stock | 2022-03-01 | A | A | 3,536 | $0.00 | 354,003 | D | — | — | (F3) Represents an award of 3,536 performance-based restricted units ("PRSUs") pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2021, the PRSUs noted above vested on March 1, 2022. |
| 4 | Common | Common Stock | 2022-03-01 | F | D | 11,439 | $26.63 | 350,467 | D | — | — | (F2) Represents the weighted average sale price of the shares sold ranging from $26.23 to $27.44 per share, inclusive. |